Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Supplerende postoperativ bupivacain efter ikke-kirurgisk endodontisk behandling

9. november 2026 opdateret af: New York University

Virkningerne af supplerende postoperativ 0,5 % bupivacain med 1:200.000 adrenalin efter ikke-kirurgisk endodontisk behandling på patienters livskvalitet, smerte og smertestillende forbrug

The study will investigate the impact of an additional injection of long-acting anesthetic on pain level, quality of life, and use of pain medication after a nonsurgical endodontic treatment. The long-acting anesthetic will be compared to a mock injection group and a group with no additional anesthetic to determine any differences in effects.

Studieoversigt

Detaljeret beskrivelse

The study will investigate the impact of postoperative supplemental long-acting bupivacaine on patient's pain, quality of life, and analgesic use following treatment for symptomatic irreversible pulpitis on patients with pre-operative pain levels of 5 or above (on a 0-10 analog scale). Bupivacaine will be compared to a placebo/mock injection and no injection to determine the difference in effect.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

150

Fase

  • Fase 2

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

  • Navn: Lorel E Burns, DDS
  • Telefonnummer: 212-998-9332
  • E-mail: leb409@nyu.edu

Undersøgelse Kontakt Backup

Studiesteder

    • New York
      • New York, New York, Forenede Stater, 10010
        • Rekruttering
        • New York University College of Dentistry
        • Kontakt:
          • Lorel E Burns, DDS, MS
          • Telefonnummer: 212-998-9332
          • E-mail: leb409@nyu.edu
        • Ledende efterforsker:
          • Lorel E Burns, DDS

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  1. Medical ASA Class I or II
  2. Patients above 18 years old
  3. Patients with a blood pressure below 160/100
  4. Patients who are treatment planned and have agreed to have emergency endodontic therapy or non-surgical root canal therapy with a pulpal diagnosis of symptomatic irreversible pulpitis according to the AAE Glossary of Endodontic Terms.
  5. Patients must be able to comprehend and complete all study protocols, written consent, and questionnaires in English.

Exclusion Criteria:

  1. Medical ASA III or above
  2. Patients who reported the use of tobacco or nicotine-containing products such as vapes, e-cigarettes, gums, or pouches and will not in the 48 hours following treatment
  3. Patients who reported the use of any marijuana products or illicit drugs in the 48 hours prior to treatment and will not in the next 48 hours.
  4. Patients who have taken opioids to control pain.
  5. Pregnant patients
  6. Patients with a blood pressure of 160/100 or greater
  7. Patients with a known hypersensitivity or allergy to any local anesthetic agent of the amide group, or any other components of the two anesthetic solutions such as epinephrine, sodium metabisulfite used in the study.
  8. Patients who have more than one tooth with odontogenic pain at the time of the screening.
  9. Patients who are unable to consent and do not understand or are unable to read the questionnaires.
  10. Patients who have had 4 1.7 ml carpules or more of anesthetic (Lidocaine and/ or Septocaine, 1:100,000) during standard care of treatment.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Supplemental Postoperative Bupivacaine

An additional injection, 1 carpule (1.8 mL) of 0.5% bupivacaine with 1:200,000 epinephrine, will be given to patients in this treatment arm, after their standard endodontic procedure is complete.

This is the intervention of interest. A supplemental injection of bupivacaine will be given postoperatively to patients who are assigned this intervention.

Placebo komparator: Mock/Placebo Injection

If assigned to this arm, the patient will be shown the removal of a needle cap for an anesthetic syringe. The tip will be bent and placed in the patient's mouth, but no tissue penetration will occur. No solution of anesthetic will be delivered.

This intervention will appear to give patients an additional injection, but no additional drug will be given.

Ingen indgriben: No Additional Injection

After standard endodontic procedure, no additional injection will be given.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Quality of life (scored based on the OHIP-14 questionnaire)
Tidsramme: Day of operation and daily for four days immediately following endodontic treatment

Quality of life will be measured with a modified version of the OHIP-14 questionnaire.

For each question, the answers correspond with a scale that runs from 0-4. A higher score corresponds with a lower quality of life, with 0 being great quality of life and 4 being very poor quality of life.

Day of operation and daily for four days immediately following endodontic treatment

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Postoperative pain level
Tidsramme: Day of operation and daily for four days immediately following endodontic treatment

Pain level as measured by the visual-analog scale (VAS) will be collected for four days following endodontic treatment.

The scale is from 0-10, with 0 being no pain and 10 being the worst pain possible.

Day of operation and daily for four days immediately following endodontic treatment
Analgesic use
Tidsramme: Day of operation and daily for four days immediately following endodontic treatment

Use of self-administered analgesics including opioids will be measured postoperatively.

The measure is binary- either usage of self-administered analgesics or no usage of self-administered analgesics.

Day of operation and daily for four days immediately following endodontic treatment

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. november 2024

Primær færdiggørelse (Anslået)

31. maj 2027

Studieafslutning (Anslået)

31. maj 2027

Datoer for studieregistrering

Først indsendt

21. oktober 2024

Først indsendt, der opfyldte QC-kriterier

21. oktober 2024

Først opslået (Faktiske)

23. oktober 2024

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

10. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

9. november 2026

Sidst verificeret

1. april 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ja

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner